Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 1, 2013
Reporting Period: The filing references financial results for the three and six months ended June 30, 2013.
Key Financial Metrics
This Form 8-K serves as a disclosure notice and does not contain specific financial data tables. The filing states that detailed results for revenue, profit, cash flow, margins, debt, and liquidity are contained in the attached exhibits (Exhibit 99.1: Conference Call Transcript; Exhibit 99.2: Press Release). The filing text itself does not provide clear values for these metrics.
Material Changes
The filing does not explicitly list material changes in financial performance within the body text. It directs readers to the conference call transcript and press release for details regarding the results for the three and six months ended June 30, 2013.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The conference call transcript contains forward-looking statements involving risks and uncertainties that may cause actual results to differ materially from those indicated.
- Risk Factors: Risks include those discussed in the attached press release and the Company's Form 10-Q for the quarter ended March 31, 2013.
- Disclaimer: Forward-looking statements are as of August 1, 2013. The Company does not intend to update these statements if views change, except as required by law.
- Legal Status: Information in Item 2.02 and exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.2 (Press Release) for specific revenue, net income, and EPS figures for the quarter and six months ended June 30, 2013.
- Examine Exhibit 99.1 (Conference Call Transcript) for management commentary on operational trends and future outlook.
- Verify the specific risk factors detailed in the referenced Form 10-Q for the quarter ended March 31, 2013.
- Confirm whether the forward-looking statements made on August 1, 2013, have been updated in subsequent filings.